Vanderhyden Lab

Barbara Vanderhyden profile picture

Contact Information

Barbara Vanderhyden, PhD
613-737-7700 ext. 70330

Ottawa Hospital Research Institute
Centre for Cancer Therapeutics
501 Smyth Road
Box 926
Ottawa, ON K1H 8L6

ORCID logo


Selected Publications

Hodgkinson K, LA Forrest, N Vuong, K Garson, B Djordjevic, and BC Vanderhyden. (2018). GREB1 is a novel estrogen receptor-regulated tumour promoter that is frequently expressed in ovarian cancer. Oncogene Jul 4. doi: 10.1038/s41388-018-0377-y. [Epub ahead of print]

Rodriguez GM, Galpin KJC, McCloskey CW and Vanderhyden BC (2018). The tumor microenvironment of epithelial ovarian cancer and its influence on response to immunotherapy. Cancers (Basel). 10(8). pii: E242. doi: 10.3390/cancers10080242. 

McCloskey CW, Rodriguez GM, Galpin KJC and Vanderhyden BC (2018). Ovarian cancer immunotherapy: Preclinical models and emerging therapeutics. Cancers (Basel). 10(8). pii: E244. doi: 10.3390/cancers10080244.

Vuong NH, O Salah Salah, and BC Vanderhyden (2017). 17β-Estradiol sensitizes ovarian surface epithelium to transformation by suppressing Dab2 expression. Scientific Reports 7: 16,702.

Alwosaibai K, A Abedini, EM Al-Hujaily, Y Tang, K Garson, O Collins and BC Vanderhyden (2017). PAX2 maintains the differentiation of oviductal epithelium and inhibits the transition to a stem cell-like state. Oncotarget 8: 76,881-76,897.

All Other Publications

Al-Hujaily EM, Y Tang, D-S Yao, E Carmona, K Garson and BC Vanderhyden (2015). Divergent roles of PAX2 in the etiology and progression of ovarian cancer. Cancer Prev. Res. 8: 1163-1173.

Garson K and Vanderhyden BC (2015). Epithelial ovarian cancer stem cells: underlying complexity of a simple paradigm. Reproduction. 149: 59-70

McCloskey CW, Goldberg RL, Carter LE, Gamwell LF, Al-Hujaily EM, Collins O, Macdonald EA, Garson K, Daneshmand M, Carmona E and Vanderhyden BC (2014). A new spontaneously transformed syngeneic model of high-grade serous ovarian cancer with a tumor-initiating cell population. Front Oncol. 4: 53.

Laviolette LA, Hodgkinson KM, Minhas N, Perez-Iratxeta C, Vanderhyden BC (2014). 17β-estradiol upregulates GREB1 and accelerates ovarian tumour progression in vivo. Int. J. Cancer. Jan 27. doi: 10.1002/ijc.28741. 

Gamwell LF, M Merziotis, K Gambaro, SL Arcand, V Snoulten, C Davis, JA Squire, DL Huntsman, PN Tonin and BC Vanderhyden (2013). Characterization of a small cell ovarian cancer cell line: Genomic anomalies and responsiveness to therapeutics. Orphanet Journal of Rare Diseases 8: 33. 

Pépin D, Paradis F, Perez-Iratxeta C, Picketts DJ, Vanderhyden BC (2013).  The imitation switch ATPase Snf2l is required for superovulation and regulates Fgl2 in differentiating mouse granulosa cells.  Biol. Reprod.. 88: 142. doi: 10.1095/biolreprod.112.105742.

Listings from The Ottawa Hospital Library

This lists the 5 most recent publications in The Ottawa Hospital's Library database from this lab.This database only starts tracking a researcher's publications once they start working at the Ottawa Hospital Research Institute.
More publications may be available in The Ottawa Hospital Library database.

PubMed Listings

For more publications use this PubMed ID link.